Abits Group Inc. (ABTS) Key Metrics
ABTS valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $3.8M
- Enterprise value
- $5.9M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 0.4 10-yr median 47.9
- Price / book
- 0.5 10-yr median 3.6
- EV / EBITDA
- 5.6 10-yr median 12.6
- Dividend yield
- —
- Beta
- 2.42
ABTS key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsABTS valuation Price multiples at each fiscal year-end price.
Price / sales−40.4%
2.2
2025 · hover or tap a bar for each year
20162025
Price / book−46.8%
1.3
2025 · hover or tap a bar for each year
20162025
EV / EBITDA−58.0%
5.3
2025 · hover or tap a bar for each year
20162025
Free cash flow yield−21.1 pts
−23.9%
2025 · hover or tap a bar for each year
20162025
ABTS returns How much profit the business earns on the capital it uses.
Return on equity+2.2 pts
−6.4%
2025 · hover or tap a bar for each year
20162025
Return on invested capital−36.4 pts
−9.3%
2025 · hover or tap a bar for each year
20162025
Return on assets+2.6 pts
−5.3%
2025 · hover or tap a bar for each year
20162025
Free cash flow margin−41.8 pts
−51.9%
2025 · hover or tap a bar for each year
20162025
Asset turnover−18.9%
0.46
2025 · hover or tap a bar for each year
20162025
ABTS per-share figures Results divided by the shares outstanding at year-end.
Revenue per share−16.4%
$2.37
2025 · hover or tap a bar for each year
20162025
Earnings per share
−$0.27
2025 · hover or tap a bar for each year
20162025
Free cash flow per share
−$1.23
2025 · hover or tap a bar for each year
20162025
Book value per share−6.3%
$4.10
2025 · hover or tap a bar for each year
20162025
Shares outstanding0.0%
2.4M
2025 · hover or tap a bar for each year
20162025
ABTS financial health Debt, liquidity and how easily interest is covered.
Debt / equity
0.23
2025 · hover or tap a bar for each year
20162025
Net debt+$3.3M
$2.2M
2025 · hover or tap a bar for each year
20162025
Net debt / EBITDA+1.39
0.79
2025 · hover or tap a bar for each year
20162025
Current ratio−89.5%
0.18
2025 · hover or tap a bar for each year
20162025
Interest coverage
-6.9
2025 · hover or tap a bar for each year
20162025
Debt / assets
0.17
2025 · hover or tap a bar for each year
20162025
ABTS efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding−20 days
1 days
2025 · hover or tap a bar for each year
20162025
Days payables outstanding+13 days
13 days
2025 · hover or tap a bar for each year
20162025
Cash conversion cycle−34 days
-13 days
2025 · hover or tap a bar for each year
20162025
Capex / revenue+38.5 pts
77.2%
2025 · hover or tap a bar for each year
20162025
ABTS valuation history
Fiscal year-endToday10-year median
ABTS returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
ABTS debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
ABTS price vs earnings per share
Share price at year-endEPS (right axis)
ABTS key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $12.2M | $24.5M | $40.5M | $15.4M | $54.2M | $26.7M | $40.8M | $23.0M | $256.3M | $257.6M |
| Enterprise value | $14.4M | $23.4M | $39.6M | $12.9M | $51.6M | $27.0M | $41.1M | $30.0M | $258.8M | $260.1M |
| P/E ratio | — | — | — | — | — | 367.1 | 135.8 | — | — | — |
| Price / sales | 2.2 | 3.6 | 24.1 | 93.9 | 246.9 | 28.2 | 110.2 | 67.6 | — | — |
| Price / book | 1.3 | 2.4 | 3.6 | 0.6 | 8.2 | 66.6 | 118.1 | — | — | — |
| Price / operating cash flow | 8.6 | 12.8 | 23.1 | — | — | — | — | — | — | — |
| EV / sales | 2.6 | 3.5 | 23.6 | 78.7 | 235.5 | 28.6 | 110.9 | 88.1 | — | — |
| EV / EBITDA | 5.3 | 12.6 | — | — | — | 96.9 | — | — | — | — |
| Earnings yield | −5.3% | −3.8% | −31.1% | −146.7% | −5.1% | 0.3% | 0.7% | −37.4% | −5.3% | −5.4% |
| Free cash flow yield | −23.9% | −2.8% | −18.5% | −259.2% | −2.0% | −6.5% | −2.9% | −26.8% | −3.4% | −3.1% |
| Share price at fiscal year-end | $5.15 | $10.33 | $17.10 | $6.77 | $42.90 | $20.70 | $31.65 | $25.57 | $288.75 | $238.50 |
| Per share | ||||||||||
| Revenue per share | $2.37 | $2.83 | $0.71 | $0.07 | $0.17 | $0.73 | $0.29 | $0.38 | $0.10 | $0.02 |
| Earnings per share | −$0.27 | −$0.39 | −$5.32 | −$9.93 | −$2.17 | $0.06 | $0.23 | −$9.57 | −$15.43 | −$12.79 |
| Operating cash flow per share | $0.60 | $0.81 | $0.74 | −$3.21 | −$0.87 | −$1.35 | −$0.91 | −$6.85 | −$9.70 | −$6.95 |
| Free cash flow per share | −$1.23 | −$0.29 | −$3.16 | −$17.54 | −$0.87 | −$1.35 | −$0.91 | −$6.85 | −$9.78 | −$7.43 |
| Cash per share | $0.04 | $0.47 | $0.37 | $1.10 | $1.99 | $0.00 | $0.03 | $0.34 | $0.02 | $0.13 |
| Book value per share | $4.10 | $4.38 | $4.77 | $10.48 | $5.20 | $0.31 | $0.27 | −$11.55 | −$3.33 | −$0.01 |
| Tangible book value per share | $3.06 | $4.27 | $4.27 | $7.38 | $1.24 | $0.31 | −$0.12 | −$11.55 | −$3.33 | −$0.01 |
| Capex per share | $1.83 | $1.10 | $3.90 | $14.34 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.49 |
| Debt per share | $0.95 | — | — | — | — | $0.28 | $0.23 | $8.13 | $2.77 | $2.36 |
| Shares outstanding | 2.4M | 2.4M | 2.4M | 2.3M | 1.3M | 1.3M | 1.3M | 898K | 888K | 1.1M |
| Change in shares outstanding | −0.0% | 0.0% | +3.9% | +80.7% | −2.1% | 0.0% | +43.6% | +1.2% | −17.8% | −19.0% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −6.4% | −8.6% | −71.6% | −148.6% | −78.6% | 19.5% | — | — | — | — |
| Return on invested capital (ROIC) | −9.3% | 27.1% | −54.7% | −119.5% | −94.1% | 10.7% | — | — | — | −235.8% |
| Return on assets (ROA) | −5.3% | −7.9% | −68.4% | −140.4% | −54.6% | 3.6% | 29.4% | — | −375.4% | −135.3% |
| Return on tangible assets | −6.1% | −8.4% | −113.3% | −129.8% | −100.1% | 3.2% | 24.2% | — | — | −232.8% |
| Free cash flow margin | −51.9% | −10.1% | −445.7% | — | −502.6% | −183.2% | −318.0% | — | — | — |
| Income quality (OCF / net income) | — | — | — | — | — | −23.85 | −3.92 | — | — | — |
| Financial health | ||||||||||
| Total debt | $2.2M | — | — | — | — | $359,549 | $301,581 | $7.3M | $2.5M | $2.6M |
| Cash & short-term investments | $94,132 | $1.1M | $884,199 | $2.5M | $2.5M | $5,249 | $38,019 | $303,962 | $18,494 | $142,170 |
| Net debt | $2.2M | −$1.1M | −$884,199 | −$2.5M | −$2.5M | $354,300 | $263,562 | $7.0M | $2.4M | $2.4M |
| Debt / equity | 0.23 | — | — | — | — | 0.90 | 0.87 | — | — | — |
| Debt / assets | 0.17 | — | — | — | — | 0.16 | 0.17 | 24.02 | 1.81 | 0.43 |
| Net debt / EBITDA | 0.79 | −0.60 | — | — | — | 1.27 | — | — | — | — |
| Current ratio | 0.18 | 1.69 | 1.65 | 7.97 | 2.34 | 1.21 | 0.89 | 0.03 | 0.04 | 0.12 |
| Quick ratio | 0.18 | 1.69 | 2.42 | 7.97 | 6.61 | 1.21 | 0.89 | 0.03 | 0.04 | 0.12 |
| Interest coverage | -6.9 | 106.2 | -584.3 | — | -46.2 | — | — | -140.8 | — | — |
| Working capital | −$2.7M | $687,290 | $652,936 | $4.3M | $1.6M | $400,773 | −$152,660 | −$10.4M | −$4.1M | −$5.2M |
| Invested capital | $11.9M | $9.3M | $10.4M | $21.4M | $4.1M | $755,073 | $609,165 | −$3.4M | −$519,545 | $2.4M |
| Tangible asset value | $7.2M | $10.1M | $10.1M | $16.8M | $1.6M | $400,773 | −$152,660 | −$10.4M | −$3.0M | −$10,162 |
| Net current asset value | −$2.7M | $687,290 | $652,936 | $4.3M | $1.6M | $400,773 | −$152,660 | −$10.4M | −$4.1M | −$5.2M |
| Graham number | — | — | — | — | — | $0.63 | $1.19 | — | — | — |
| Graham net-net per share | −$1.35 | $0.05 | $0.03 | $1.61 | −$0.78 | −$0.13 | −$0.35 | −$11.55 | −$4.84 | −$5.06 |
| Capital allocation | ||||||||||
| Capex / revenue | 77.2% | 38.7% | 550.1% | 19,891.4% | 0.0% | 0.0% | 0.0% | 0.0% | 74.3% | 2,446.0% |
| Capex / operating cash flow | 306.1% | 135.5% | 526.8% | — | — | — | — | — | — | — |
| Capex / depreciation | 1.23 | 0.99 | 1.86 | 5.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.28 |
| R&D / revenue | — | — | — | — | — | — | — | 661.0% | 2,328.0% | 12,065.5% |
| SG&A / revenue | 28.1% | 31.1% | 87.4% | 1,520.2% | — | 92.3% | — | — | — | — |
| Efficiency | ||||||||||
| Days sales outstanding | 0.8 | 21.1 | 342.9 | 2,902.1 | 2,096.9 | 674.1 | 1,187.9 | — | — | 7,557.0 |
| Days of inventory on hand | — | — | -620.5 | — | — | — | — | — | 2.1 | 4.7 |
| Days payables outstanding | 13.3 | -0.0 | 0.0 | — | — | — | — | — | — | — |
| Cash conversion cycle (days) | -12.5 | 21.1 | -277.7 | — | — | — | — | — | — | — |
| Receivables turnover | 479.93 | 17.33 | 1.06 | 0.13 | 0.17 | 0.54 | 0.31 | — | — | 0.05 |
| Payables turnover | 27.51 | — | — | — | — | — | — | — | — | — |
| Inventory turnover | — | — | — | — | — | — | — | — | 171.43 | 78.43 |
| Asset turnover | 0.46 | 0.57 | 0.09 | 0.01 | 0.04 | 0.47 | 0.36 | 0.41 | 0.03 | 0.00 |
| Average receivables | $11,683 | $387,172 | $1.6M | $1.3M | $1.3M | $1.7M | $1.2M | — | — | $444,701 |
| Average payables | $157,364 | $0 | $0 | — | — | — | — | — | — | — |
| Average inventory | — | — | −$774,345 | — | −$5.0M | — | — | — | $6,494 | $24,084 |
| Intangibles / total assets | 19.1% | 2.3% | 9.7% | 28.9% | 64.6% | 0.0% | 28.6% | 0.0% | 0.0% | 0.0% |
Computed from ABTS's annual financial statements (latest annual report filed September 30, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
ABTS valuation and financial ratios
Abits earned a return on equity of −6.4% and a return on invested capital of −9.3% in fiscal 2025. It ended the year with $2.2 million of debt and $0.1 million in cash and short-term investments, net debt of $2.2 million. The share count rose 119.4% from 1.1M to 2.4M over 9 years.
See the ABTS income statement, the ABTS chart for price history, or the ABTS stock overview for the latest quote and news.
ABTS key metrics FAQ
What is Abits's EV/EBITDA?
Abits's enterprise value was 5.3 times EBITDA at the end of fiscal 2025 (enterprise value $14.4 million, EBITDA $2.7 million); the current EV/EBITDA is 5.6.
What is Abits's return on equity?
Abits's return on equity (ROE) was −6.4% in fiscal 2025: net income of -$0.6 million on average shareholders' equity of $10.1 million.
What is Abits's ROIC?
Abits's return on invested capital was −9.3% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Abits have?
Abits had total debt of $2.2 million at the end of fiscal 2025, a debt-to-equity ratio of 0.23 and $2.2 million of net debt (0.79 times EBITDA).
What is Abits's free cash flow yield?
Abits generated -$2.9 million of free cash flow in fiscal 2025, a free cash flow yield of −23.9% on its market value at year-end ($12.2 million).
What is Abits's current ratio?
Abits's current ratio was 0.18 at the end of fiscal 2025: current assets were 0.18 times current liabilities.